Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Twister Biotech

Twister Biotech
2011 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
1 INVESTORS
Description

Developer of gene therapies designed to provide MiniVectors. The company's gene therapies are a result of research, development and commercialization of supercoiled DNA minicircles for transfer of DNA into primary and stem cells, enabling researchers to get better transfection efficiencies and longer-term effects.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • PO Box 20566
  • Houston, TX 77225
  • United States

+1 (713) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Twister Biotech’s full profile, request a free trial.

Twister Biotech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Twister Biotech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BCM Technologies Venture Capital Minority 000 0000 000000 0

Twister Biotech Executive Team (4)

Name Title Board
Seat
Contact
Info
Lynn Zechiedrich Ph.D Co-Founder, President, Chief Scientific Officer & Co-Chief Executive Officer
Jamie Catanese Ph.D Co-inventor, Co-founder, Shareholder & Scientific Advisor
Christopher Coker Co-Chief Education Officer

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »